This HTML5 document contains 169 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34331649
rdf:type
wikibase:Item
schema:description
2004年论文 wissenschaftlicher Artikel artículu científicu espublizáu en 2004 سائنسی مضمون 2004年论文 مقالهٔ علمی 2004 nî lūn-bûn wetenschappelijk artikel научни чланак επιστημονικό άρθρο 2004年論文 artigo científico artículo científico publicado en 2004 article scientifique (publié 2004) vitskapeleg artikkel articolo scientifico 2004年论文 mokslinis straipsnis научная статья vetenskaplig artikel мақолаи илмӣ 2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած scienca artikolo мақолаи илмӣ 2004年論文 vitenskapelig artikkel 2004 թվականի հուլիսին հրատարակված գիտական հոդված artigo científico (publicado na 2004) artykuł naukowy artikulong pang-agham artigo científico (publicado na 2004) 2004年论文 bài báo khoa học tudományos cikk naučni članak 2004年論文 مقالة علمية 2004年论文 บทความทางวิทยาศาสตร์ ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ სამეცნიერო სტატია bilimsel makale 2004年の論文 article scientific scientific article 2004年论文 научна статия videnskabelig artikel (udgivet 2004) tieteellinen artikkeli научни чланак наукова стаття, опублікована в липні 2004 vedecký článok מאמר מדעי 2004年論文 artikull shkencor 2004년 논문 vědecký článek teaduslik artikkel article científic articol științific 2004年論文
p:P577
wds:Q34331649-E6263EEB-73BE-4BE4-A53C-5C026B4FFF78
wdt:P577
2004-07-01T00:00:00Z
p:P407
wds:Q34331649-5469DF26-5B25-4FF4-8832-25D8562137CA
wdt:P407
wd:Q1860
p:P2093
wds:Q34331649-F23AAC98-797E-48D5-8516-2418A659528E wds:Q34331649-9620D162-0A71-42F6-A1DB-19D344FA6AF3 wds:Q34331649-97A1FB63-03E2-4C42-8A27-07D8D43A8E07 wds:Q34331649-34C073D0-8DD0-433C-A137-B733F8140613 wds:Q34331649-373A24B9-1508-42F9-8729-78897EC2A625 wds:Q34331649-5399250B-8D54-4720-90C2-8BF8583C4E04
wdt:P2093
Marty J Frey Marc Cohen Ed Fry James J Ferguson Jacques Col Steven Borzak
rdfs:label
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial
skos:prefLabel
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial
schema:name
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial
p:P50
wds:Q34331649-65442300-66C1-4C69-8B86-F4D69961DEAE wds:Q34331649-68C53EB8-F908-4664-89A5-7231877FEF8A wds:Q34331649-75E243E9-9739-4112-9C4D-EFCF2C99AB41 wds:Q34331649-796CC644-0355-4A94-8E51-D8F348ABA28C wds:Q34331649-81E12EF3-8C45-4A13-8606-BB1FCAEDD452 wds:Q34331649-8361E90C-8AF6-4CA0-9B57-07CBD76D88CF wds:Q34331649-840D05F4-7FBC-4E14-A27D-7C0B5881B205 wds:Q34331649-8A49C9F0-2908-4171-A39D-CD8B16B76EC1 wds:Q34331649-3B22FBCD-EAB5-48D5-97E5-83132B13ECD5 wds:Q34331649-40A5759D-0810-4F4D-8C87-1C1082C4ABE5 wds:Q34331649-4D3602A4-DAE3-4339-91F2-B3CD550F8A09 wds:Q34331649-636700FB-C007-40CC-8202-620AC70DCA8E wds:Q34331649-0FCF6FDC-9371-4A4E-88A3-0CD972F55918 wds:Q34331649-13BCFA60-4DCC-4620-8023-BB488F5E4F74 wds:Q34331649-200B9BF6-190E-4211-972C-0A37BC9B06F4 wds:Q34331649-25F93F62-A4AB-4A48-B9BB-72B3D438F6D5 wds:Q34331649-328A01BB-CC3C-452A-87C7-48209AAB47A8 wds:Q34331649-ED27394E-EA47-4377-B8A4-6C8890B279E3 wds:Q34331649-F2761F03-B9BB-443C-BEA7-AF4A1196B73C wds:Q34331649-F2ED0D3F-716D-49B0-96CE-E49D3A9CBC27 wds:Q34331649-FA6DF6E4-FE1A-4398-B87B-CD6AB8DB54A7 wds:Q34331649-FE9CAEFD-A42F-4F4F-88D1-B61B01B27FAA wds:Q34331649-D40CF94E-EC60-4E64-864A-F33913F76636 wds:Q34331649-D9E9A9AF-BFCE-48BD-ADC0-AA77F0EFC912 wds:Q34331649-E8F8DE14-5190-4BC1-A6BD-062CF1D03E0C wds:Q34331649-8ADE87E6-D5F7-48E5-8A28-8B9F5D086B80 wds:Q34331649-90DBBA64-DB2D-4737-8DB9-CA1859FD7C50 wds:Q34331649-9788C386-F1F0-4E16-AAB2-6E1B1209554A
wdt:P50
wd:Q64496972 wd:Q91304252 wd:Q114427091 wd:Q103008262 wd:Q19281782 wd:Q114304362 wd:Q63101609 wd:Q64684123 wd:Q114427092 wd:Q114292254 wd:Q114292266 wd:Q62914910 wd:Q60546641 wd:Q48865428 wd:Q57243679 wd:Q112156984 wd:Q57013135 wd:Q57079766 wd:Q114292253 wd:Q9375823 wd:Q114292256 wd:Q39026591 wd:Q39730635 wd:Q114561273 wd:Q86719882 wd:Q112157008 wd:Q114427080 wd:Q1587897
p:P1476
wds:Q34331649-BC92ECF8-7AB7-4E25-9102-9A3212E101C2
wdt:P1476
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial
p:P304
wds:Q34331649-FEAA1F67-D16F-40DF-95C6-2096AE081E7E
wdt:P304
45-54
p:P31
wds:Q34331649-135692E5-A6E2-48D0-B609-75369833E9EF
wdt:P31
wd:Q13442814
p:P921
wds:Q34331649-B86DC85A-2653-45A9-BEF3-370743EA5AAB wds:Q34331649-D104335C-179C-44C6-B200-B26E3803B773 wds:Q34331649-082F5C88-185E-4ED0-9DD7-512B0E357E54
wdt:P921
wd:Q181600 wd:Q266018 wd:Q190016
p:P698
wds:Q34331649-A6869A58-1398-45C2-A05F-004D37D7DEA8
wdtn:P698
n9:15238590
wdt:P698
15238590
p:P1433
wds:Q34331649-D4C453A1-17D4-4BF7-A627-D79C1BC953C9
wdt:P1433
wd:Q1470970
p:P433
wds:Q34331649-2E639D62-0DB5-474E-9814-D96657491DAF
p:P478
wds:Q34331649-A3D5055B-3097-4611-8427-2D26F39AFBC3
wdt:P433
1
wdt:P478
292
p:P1104
wds:Q34331649-0850ED24-FE5B-42B0-843A-CBAD4D45A6F7
wdt:P1104
10
p:P356
wds:Q34331649-92B16FEC-5971-42F7-8809-B49EC4EB2E63
wdtn:P356
n12:JAMA.292.1.45
wdt:P356
10.1001/JAMA.292.1.45